	Persistent Gaps in Inclusion of Racial and Ethnic Minorities in Nail Psoriasis Randomized Clinical Trials: A Systematic Review. Cutis Chalupczak NV, Ricardo JW, Lipner SR. PMID: 42868304 [PubMed - in process]
	Psoriasis Area and Severity Index Use in Pediatric Psoriasis. Cutis Patra P, Parker L, Albers S. PMID: 42868296 [PubMed - indexed for MEDLINE]
	Smoking Status and Psoriasis Risk: An Updated Systematic Review and Meta-Analysis. Dermatology Ye Y, Lim JJ, Huang Z, Chew FT. PMID: 42868059 [PubMed - as supplied by publisher]
	Frequency and Clinicohistopathological Concordance of Psoriasis and Psoriasiform Dermatitis: A Tertiary Care Study. Cureus Raghuvanshi R, Shashikant, Ali M, Meena HS, Sukheja C, Gupta I. PMID: 42866419 [PubMed]
	Comparative drug survival of biologic classes in psoriasis: a Japanese single-centre cohort study. Eur J Dermatol Watabe D, Tsunoda K, Hamabata A, Goto M, Yoshioka W, Amano H. PMID: 42862174 [PubMed - indexed for MEDLINE]
	Biologic treatments for palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and network meta-analysis. Eur J Dermatol Ayén-Rodríguez A, Ruiz-Villaverde R, Husein-Elahmed H. PMID: 42862173 [PubMed - indexed for MEDLINE]
	Effects of Switching From Deucravacitinib to Tildrakizumab in Psoriasis: A 28-Week Real-World Study. J Psoriasis Psoriatic Arthritis Takahashi Y, Hagino T, Yoneyama M, Shiba M, Saeki H, Fujimoto E, Kanda N. PMID: 42861124 [PubMed - as supplied by publisher]
	Bimekizumab efficacy across GRAPPA domains to 3 years in patients with psoriatic arthritis: a post hoc analysis of two phase 3 studies. Rheumatology (Oxford) Deodhar A, Gottlieb AB, Merola JF, Soriano ER, Coates LC, Ink B, Bajracharya R, Healy P, Mease PJ. PMID: 42860055 [PubMed - as supplied by publisher]
	Distinct clinical profiles of methotrexate intolerance and hepatotoxicity in psoriatic arthritis. ARP Rheumatol Macia-Villa C, Ferre-Sanfrancisco M, Ruiz-Bejerano AM, Morell-Hita JL. PMID: 42859983 [PubMed - indexed for MEDLINE]
	Functional characterization of genetic variants associated with response to tumor necrosis factor inhibitors in psoriatic arthritis patients. Autoimmun Rev Planaki A, Simopoulou T, Giannoulis T, Zafiriou E, Bogdanos DP, Sarafidou T, Liadaki K. PMID: 42858919 [PubMed - as supplied by publisher]
	Interplay of Biological Treatment and Psychological Features in Patients with Psoriasis: A Real-Life Prospective Study. Dermatol Pract Concept Moretta G, Samela T, Provini A, Pagnanelli G, Graceffa D, Orsini D, Lora V, Richetta AG, Dattola A, Amato S, Bernardini N, Tribuzi P, Zangrilli A, Vultaggio M, Bianchi L, Caldarola G, De Luca E, De Simone C, Giordano D, Masini C, Bavetta M, Lechiancole S, Panasiti V, Abeni D. PMID: 42858446 [PubMed]
	Arthralgia in Patients with Chronic Plaque Psoriasis: Practical Insights for Dermatologists. Dermatol Pract Concept Gisondi P, Bellinato F, Errichetti E, Idolazzi L, Zabotti A. PMID: 42858420 [PubMed]
	Shared Pathways between Psoriasis and Atopic Dermatitis. Dermatol Pract Concept Trovato F, Chello C, Amato S, Di Guardo A, Amore E, Bennardo L, Richetta AG, Grieco T, Nisticò SP, Pellacani G, Dattola A. PMID: 42858415 [PubMed]
	One-Year Real-Life Data from Thai Patients with Moderate to Severe Plaque Psoriasis Treated with Secukinumab - Outcomes from the PROMPT Study. Dermatology Asawanonda P, Chularojanamontri L, Chuamanochan M, Amornpinyo W, Pongcharoen P, Laodheerasiri S, Pattamadilok B, Choonhakarn C, Sangmala S, Pretikul N, Boonsiri M, Sangob N, Rattanakaemakorn P. PMID: 42858283 [PubMed - as supplied by publisher]
	Effect of abatacept on bone in patients with psoriatic arthritis-results from a prospective interventional high-resolution imaging study (ABEPSA). EULAR Rheumatol Open Temiz A, Yalcin-Mutlu M, Corte G, Bayat S, Schuster L, Simon D, Rech J, Werner D, Tascilar K, Fagni F, Roemer F, Schett G, Kleyer A. PMID: 42857349 [PubMed]
	From drug mechanism-based to driver-guided therapy: targeting disease drivers in psoriatic arthritis. EULAR Rheumatol Open Witte T, Kleyer A, Ciccia F, Simon D. PMID: 42856860 [PubMed]
	Does articular and entheseal structural damage drive pain and patient-driven reported outcomes in patients with difficult-to-treat psoriatic arthritis? Results from a cross-sectional study. EULAR Rheumatol Open Perrotta FM, Zabotti A, Fatica M, Cabas N, Guiotto A, Franzolini N, Giovannini I, De Martino M, Di Nicola C, Isola M, Di Matteo A, De Marco G, McGonagle D, Quartuccio L, Lubrano E. PMID: 42856858 [PubMed]
	Effectiveness of interleukin (IL)-23 and IL-12/23 inhibitors and factors associated with response in psoriatic arthritis with axial involvement: the APxis-IL12-23 study. Scand J Rheumatol Almodóvar R, Mazzucchelli R, Pérez-Fernández E, Trujillo E, Navarro P, Sanz-Sanz J, Joven B, Valero C, García-Vicuña R, Queiro R, Loredo M, Alvarez P, Martín de la Sierra López L, Castro Corredor D, Paulino Huertas M, Galíndez-Agirregoikoa E, García Vivar ML, Vergara-Dangond C, Terán A, Trives-Folguera L, Muñoz-Fernández S, Llop M, Moreno M, Gratacós J, Aparicio M, Mateo L, González L, Pinto Tasende JA, Fernández-Carballido C, Villaverde V, Marín C, Gómez C, Navío T, García Llorente F, Moreno M, Linares L, Moreno MJ, Alvarez C, González I, Urruticoechea-Arana A, Ramírez J, Del Olmo L, Zarco P, Beltrán E. PMID: 42852579 [PubMed - as supplied by publisher]
	Efficacy and Safety of Treatment with Methotrexate Versus a Combination of Low Dose of Methotrexate Plus Low Dose of Acitretin in Chronic Plaque Psoriasis: A Randomised Nonblinded Controlled Trial. Indian Dermatol Online J Singh SK, De S. PMID: 42849024 [PubMed - as supplied by publisher]
	Changes in the FIB-4 index with IL-23 vs IL-17 inhibitors in psoriasis: a retrospective cohort study. Expert Opin Biol Ther Uluta, Demirbas A, Diremsizoglu E. PMID: 42848523 [PubMed - as supplied by publisher]

Articles 1 - 20 / 28630

Page 1 of 1432



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy